Clincosm LogoSign in Get a demo

The Effect of Education on Nurses' Knowledge About High-flow Nasal Cannula Oxygen Therapy

Sponsor
Izmir Katip Celebi University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05362279
Collaborator
(none)
70
Enrollment
2
Arms
3
Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

This study was conducted to evaluate the oxygen therapy methods used in pediatric services and to specify the roles and responsibilities of nurses in the application of HFNC, which is one of these methods. Although the decision to implement this treatment method is under the responsibility of the physician in Turkey, the use of the device, observing the effectiveness of the treatment, monitoring and recording the changes in the vital signs of the children are under the responsibility of the nurses shows the importance of the nursing perspective on HFNC.

Condition or Disease Intervention/Treatment Phase
  • Other: Training
 N/A

Detailed Description

High-flow nasal cannula oxygen therapy (HFNC) which meets the patient's ventilation need is a non-invasive ventilation system in which warmed and humidified oxygen is administered to the patient at varying flows with the help of a nasal cannula.This study will be conducted as a randomized controlled study with the participation of 70 nurses working in the pediatric clinics of a public hospital between December 2021 and May 2022, as an experimental group (n=35) and a control group (n=35). In the study, two-stage sampling method will be used to determine the nurses who will take place in the experimental and control groups. After the nurses are stratified according to their professional years, assignment to the experimental and control groups will be made by simple random sampling method. The experimental group will be given a pre-test before the training and a post-test one month after the training. In order to avoid interaction between the two groups, the data of the nurses in the control group will be collected first. The knowledge level of the nurses in the experimental and control groups will be evaluated with the HFNC Information Form.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized controlled study with pretest-posttest experimental and control groupsRandomized controlled study with pretest-posttest experimental and control groups
Masking:
Single (Participant)
Primary Purpose:
Other
Official Title:
The Effect of Training on Oxygen Therapy With High Flow Nasal Cannula on the Knowledge Level of Pediatric Nurses; A Randomized Controlled Trial
Anticipated Study Start Date :
May 10, 2022
Anticipated Primary Completion Date :
Jun 10, 2022
Anticipated Study Completion Date :
Aug 10, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Test after post-test training

Pre-test will be applied to the nurses in the experimental group before the training. The post-test will be applied to the experimental group, to which the pre-test was applied, one month after the training was given.

Other: Training
One month after the pre-test, the post-test will be administered to the nurses who will be in the control group. Nurses who will be in the experimental group will be given training after the pre-test. A post-test will be administered one month after the training.
No Intervention: Test without training

The nurses in the control group are the group to be administered the post-test without any intervention after the pre-test. The post-test will be administered one month after the pre-test.

Outcome Measures

Primary Outcome Measures

  1. Knowledge Level - Education Form- Questionnaire [One month after training]

    To increase the knowledge level of nurses about oxygen therapy with high flow nasal cannula.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

  • Nurses working in any of the pediatric emergency departments, pediatric clinics

  • No previous training in HFNC treatment

  • Follow-up of patients treated with HFNC

  • Volunteering to participate in research

Exclusion Criteria:

  • Those who have received in-service training on HFNC implementation

  • Those who work as responsible nurses or training nurses in the clinics where the research will be conducted

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Izmir Katip Celebi University

Investigators

  • Principal Investigator: Aslı ALACA, Study Principal Investigator

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Aslı Alaca, Principal Investigator, Izmir Katip Celebi University
ClinicalTrials.gov Identifier:
NCT05362279
Other Study ID Numbers:
  • AAlaca
First Posted:
May 5, 2022
Last Update Posted:
May 5, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Aslı Alaca, Principal Investigator, Izmir Katip Celebi University
HFNC
Nursing Care
Knowledge Level
Education

Study Results

No Results Posted as of May 5, 2022